Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,313 | 1,284 | 99.4% |
| Education | $72.61 | 11 | 0.3% |
| Gift | $60.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,977 | 177 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,401 | 135 | $0 (2024) |
| Amarin Pharma Inc. | $2,126 | 116 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,624 | 98 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,524 | 73 | $0 (2024) |
| Lilly USA, LLC | $1,338 | 92 | $0 (2024) |
| Amgen Inc. | $1,295 | 65 | $0 (2024) |
| PFIZER INC. | $1,261 | 107 | $0 (2024) |
| ABBVIE INC. | $1,024 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $738.13 | 40 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,142 | 100 | Novo Nordisk Inc ($331.96) |
| 2023 | $2,620 | 138 | AbbVie Inc. ($398.94) |
| 2022 | $2,548 | 145 | GlaxoSmithKline, LLC. ($258.67) |
| 2021 | $3,106 | 180 | Amarin Pharma Inc. ($447.31) |
| 2020 | $2,931 | 176 | Amarin Pharma Inc. ($635.89) |
| 2019 | $2,933 | 179 | AstraZeneca Pharmaceuticals LP ($469.28) |
| 2018 | $3,223 | 187 | Novo Nordisk Inc ($494.08) |
| 2017 | $2,943 | 191 | AstraZeneca Pharmaceuticals LP ($547.58) |
All Payment Transactions
1,296 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $79.96 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.63 | General |
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: DIABETES | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Obesity | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Biological | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,924 | 3,997 | $734,115 | $217,204 |
| 2022 | 27 | 2,022 | 4,059 | $686,287 | $220,719 |
| 2021 | 30 | 2,573 | 5,341 | $699,079 | $259,213 |
| 2020 | 34 | 2,747 | 5,313 | $649,069 | $237,672 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 434 | 1,498 | $479,360 | $125,232 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 322 | 322 | $104,972 | $40,127 | 38.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $20,590 | $8,160 | 39.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 115 | 115 | $18,860 | $8,128 | 43.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 37 | $25,604 | $8,029 | 31.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 398 | 837 | $13,540 | $6,922 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 118 | $26,904 | $6,059 | 22.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 115 | $8,510 | $3,478 | 40.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $5,880 | $2,295 | 39.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 28 | $5,063 | $1,449 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 28 | 30 | $5,040 | $1,244 | 24.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 20 | $1,560 | $1,190 | 76.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 37 | 50 | $4,200 | $1,078 | 25.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 105 | $3,780 | $995.49 | 26.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $1,702 | $695.52 | 40.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 125 | $1,375 | $495.60 | 36.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 23 | 37 | $925.00 | $352.24 | 38.1% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 12 | $1,188 | $310.00 | 26.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 78 | $1,326 | $307.06 | 23.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 28 | $1,932 | $274.32 | 14.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 52 | 69 | $414.00 | $143.25 | 34.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 138 | $552.00 | $112.89 | 20.5% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $462.00 | $46.74 | 10.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 30 | $120.00 | $32.15 | 26.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 72 | $144.00 | $26.45 | 18.4% |
About Dr. David White, MD
Dr. David White, MD is a Family Medicine healthcare provider based in Yulee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982673786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David White, MD has received a total of $22,446 in payments from pharmaceutical and medical device companies, with $2,142 received in 2024. These payments were reported across 1,296 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($22,313).
As a Medicare-enrolled provider, White has provided services to 9,266 Medicare beneficiaries, totaling 18,710 services with total Medicare billing of $934,808. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Yulee, FL
- Active Since 03/15/2006
- Last Updated 12/12/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982673786
Products in Payments
- Vascepa (Drug) $2,126
- FARXIGA (Drug) $1,454
- JARDIANCE (Drug) $1,252
- Ozempic (Drug) $1,032
- TRELEGY ELLIPTA (Drug) $923.46
- Victoza (Drug) $636.94
- XARELTO (Drug) $614.31
- CHANTIX (Drug) $537.50
- Dexcom G6 Transmitter (Medical Supply) $502.01
- Aimovig (Biological) $436.00
- MOUNJARO (Drug) $402.27
- Rybelsus (Drug) $393.07
- TRULICITY (Drug) $390.05
- SYMBICORT (Drug) $372.60
- VRAYLAR (Drug) $369.71
- UBRELVY (Drug) $344.91
- MYRBETRIQ (Drug) $342.66
- NURTEC ODT (Drug) $342.34
- Repatha (Biological) $339.46
- Otezla (Drug) $306.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Yulee
Thomas Taylor, M. D, M. D
Family Medicine — Payments: $23,468
Dr. Chisara Adonai, Md, MD
Family Medicine — Payments: $5,229
Dr. Obaidullah Ahmed, Md, MD
Family Medicine — Payments: $4,071
Dr. Erica Wiedl, Md, MD
Family Medicine — Payments: $534.03
Dr. Jeremy Coleman, M.d, M.D
Family Medicine — Payments: $122.87
Martha Mcdonough, D.o, D.O
Family Medicine — Payments: $41.96